Tribune Therapeutics AB
559281-1045ActiveDeveloping novel medicines to halt fibrotic disease progression across organs.
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2020
- Founded
Key Decision Makers
Georg Vo Beiske
CEO
Ole J. Kaasbøll
CSO, Co-founder
Berthold Bödeker
CTO
Mathias Locher
CDO
Description
Tribune Therapeutics is a preclinical biopharmaceutical company established in 2020, focused on creating novel medicines for treating fibrosis. Their core mission is to address fibrotic diseases regardless of the underlying cause or affected tissue, such as the heart, kidneys, or lungs. The company'...
Tags
Keywords
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559281104501
Decision Makers
4 contacts in FunnelfeedrGeorg Vo Beiske
CEO
Ole J. Kaasbøll
CSO, Co-founder
Berthold Bödeker
CTO
Mathias Locher
CDO
Similar Companies
20 similar companies in FunnelfeedrAQILION AB
5–9 employeesDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
CALLUNA PHARMA AS
10 employeesClinical stage biotech pioneering antibodies for inflammation and fibrosis.
CANTARGIA AB
20–49 employeesDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
PILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
AcroPharma AB (publ)
0 employeesDeveloping innovative preventive therapeutics for major human diseases.
Browse More
Tribune Therapeutics AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo